Molina Healthcare, Inc $MOH Stock Position Lifted by Tredje AP fonden

Tredje AP fonden raised its stake in Molina Healthcare, Inc (NYSE:MOH) by 119.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 9,968 shares of the company’s stock after buying an additional 5,424 shares during the quarter. Tredje AP fonden’s holdings in Molina Healthcare were worth $1,907,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of MOH. Norges Bank acquired a new position in shares of Molina Healthcare in the second quarter worth $212,113,000. Invesco Ltd. grew its stake in Molina Healthcare by 25.9% in the second quarter. Invesco Ltd. now owns 1,601,574 shares of the company’s stock valued at $477,109,000 after purchasing an additional 329,759 shares in the last quarter. Rakuten Investment Management Inc. purchased a new position in Molina Healthcare in the third quarter valued at about $56,592,000. Vaughan Nelson Investment Management L.P. acquired a new position in Molina Healthcare in the 3rd quarter worth about $52,813,000. Finally, Viking Global Investors LP purchased a new stake in shares of Molina Healthcare during the 2nd quarter worth about $79,665,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on MOH. Barclays lowered their price target on Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating for the company in a research note on Tuesday, February 10th. Deutsche Bank Aktiengesellschaft set a $109.00 price target on shares of Molina Healthcare in a research note on Tuesday, February 10th. TD Cowen cut their price target on shares of Molina Healthcare from $175.00 to $144.00 and set a “hold” rating on the stock in a report on Monday, February 9th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a report on Thursday, January 22nd. Finally, Truist Financial lowered their target price on shares of Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a research report on Tuesday, February 17th. Two investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $157.86.

Molina Healthcare Price Performance

Shares of Molina Healthcare stock opened at $150.88 on Monday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.97. The firm has a fifty day simple moving average of $169.15 and a 200-day simple moving average of $169.01. The stock has a market capitalization of $7.77 billion, a price-to-earnings ratio of 17.63 and a beta of 0.49. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $359.97.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). The firm had revenue of $11.38 billion during the quarter, compared to the consensus estimate of $10.90 billion. Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The business’s revenue was up 8.3% compared to the same quarter last year. During the same quarter last year, the business earned $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.